Cleared Traditional

K252633 - UNITY DX (UDX) (FDA 510(k) Clearance)

Dec 2025
Decision
125d
Days
Class 2
Risk

K252633 is an FDA 510(k) clearance for the UNITY DX (UDX). This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Cylite Pty. , Ltd. (Mulgrave, AU). The FDA issued a Cleared decision on December 23, 2025, 125 days after receiving the submission on August 20, 2025.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K252633 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 2025
Decision Date December 23, 2025
Days to Decision 125 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO - Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.